ELAC2 and cardiomyopathy: Patients carrying ELAC2 variants commonly present cardiomyopathies that can be severe infantile cardiomyopathies—dilated and/or hypertrophic—often with a negative prognosis or milder cardiomyopathies, which are associated with prolonged survival.